Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,totalAssets,commonStock,retainedEarnings,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,inventory,accountsPayable,netReceivables,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToNetincome,changeToAccountReceivables,capitalExpenditures,repurchaseOfStock,WC,language,region,quoteType,triggerable,quoteSourceName,currency,priceHint,exchange,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,shortName,marketState,market,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,maxAge,address1,fax,industry
t0,INTP,487538.0,0,36290,,-439094,,-439094,199556,0,-302222,-302222,,-829,,,,0,0,302222,0,-136872,,-439094,-439094,97092.0,17883050.0,357497.0,584630.0,942127.0,470482.0,-17768562.0,-340.0,180853.0,357497.0,-340.0,485805.0,357550.0,1680.0,108384.0,273664.0,,103401.0,-3563.0,255000.0,-46072.0,255000.0,90195.0,-161242.0,141395.0,-462.0,79591.0,,,,53.0,en-US,US,EQUITY,False,Delayed Quote,USD,4,PNK,0.0001,1629379809,0.0,0.0001,0.0001,0.0001,4000,0,INTEGRATED PHARMACEUTICALS INC,PRE,us_market,0.0,1.0E-4 - 1.0E-4,0.0001,0.0,0.0,0,0,finmb_3161389,Other OTC,"Integrated Pharmaceuticals, Inc.",USD,2335,0,0.0,0.0,1.0E-4 - 0.1256,-0.1255,-0.9992038,0.0001,0.1256,-0.5,0.0035287323,-0.0034287323,-0.9716612,-0.04,0.012,0.0002,-0.0001,164668,0.008333333,15,America/New_York,EDT,-14400000,False,False,15.2,,,0.1256,0.0001,0.0002,0.0035,2.33k,,,,,,,,,,,,,3.06%,,,,0.00%,,,1:4,"Sep 19, 2000","Dec 30, 2007","Jun 29, 2008",0.00%,"-4,229.01%",-57.38%,-190.74%,27k,0.00,,23k,-594.13k,-1.7M,-0.0400,,180.85k,0,,,1.00,0.01,-908.64k,76.65k,Value,01420,Healthcare,4,"Integrated Pharmaceuticals, Inc. develops and produces specialty chemicals and nutraceuticals in the United States. It offers compounds and nutraceuticals that have proven therapeutic or nutritional value in humans, plants, and animals. The company also develops technologies for the production of clinically active pharmaceutical compounds, including active small molecules and recombinant DNA technology derived products. In addition, it offers calcium supplements that are used in soft drinks, coffee, tea, soup, dehydrated sauces, and beverages; and fortified bottled water. The company sells its products through distributors and retailers. The company was formerly known as Digital Caddies, Inc. and changed its name to Integrated Pharmaceuticals, Inc. in September 2011. The company was incorporated in 1969 and is based in Fitchburg, Massachusetts.",Fitchburg,978-696-0020,MA,1199059200,United States,86400,310 Authority Drive,978-696-0026,Drug Manufacturers—Specialty & Generic
t-1,INTP,616243.0,0,48409,,-389849,,-389849,154930,0,-269045,-269045,,-1436,,,,0,0,269045,0,-120804,,-389849,-389849,100645.0,17548096.0,254956.0,716888.0,971844.0,436103.0,-17267231.0,-80.0,90658.0,254956.0,-80.0,620084.0,249175.0,1940.0,107922.0,170456.0,27687.0,14604.0,1478.0,265000.0,-8191.0,265000.0,24155.0,-242323.0,134653.0,-462.0,6460.0,,,,-5781.0,en-US,US,EQUITY,False,Delayed Quote,USD,4,PNK,0.0001,1629379809,0.0,0.0001,0.0001,0.0001,4000,0,INTEGRATED PHARMACEUTICALS INC,PRE,us_market,0.0,1.0E-4 - 1.0E-4,0.0001,0.0,0.0,0,0,finmb_3161389,Other OTC,"Integrated Pharmaceuticals, Inc.",USD,2335,0,0.0,0.0,1.0E-4 - 0.1256,-0.1255,-0.9992038,0.0001,0.1256,-0.5,0.0035287323,-0.0034287323,-0.9716612,-0.04,0.012,0.0002,-0.0001,164668,0.008333333,15,America/New_York,EDT,-14400000,False,False,15.2,,,0.1256,0.0001,0.0002,0.0035,2.33k,,,,,,,,,,,,,3.06%,,,,0.00%,,,1:4,"Sep 19, 2000","Dec 30, 2007","Jun 29, 2008",0.00%,"-4,229.01%",-57.38%,-190.74%,27k,0.00,,23k,-594.13k,-1.7M,-0.0400,,180.85k,0,,,1.00,0.01,-908.64k,76.65k,Value,01420,Healthcare,4,"Integrated Pharmaceuticals, Inc. develops and produces specialty chemicals and nutraceuticals in the United States. It offers compounds and nutraceuticals that have proven therapeutic or nutritional value in humans, plants, and animals. The company also develops technologies for the production of clinically active pharmaceutical compounds, including active small molecules and recombinant DNA technology derived products. In addition, it offers calcium supplements that are used in soft drinks, coffee, tea, soup, dehydrated sauces, and beverages; and fortified bottled water. The company sells its products through distributors and retailers. The company was formerly known as Digital Caddies, Inc. and changed its name to Integrated Pharmaceuticals, Inc. in September 2011. The company was incorporated in 1969 and is based in Fitchburg, Massachusetts.",Fitchburg,978-696-0020,MA,1199059200,United States,86400,310 Authority Drive,978-696-0026,Drug Manufacturers—Specialty & Generic
t-2,INTP,733797.0,0,44503,,-538383,,-538383,284375,0,-410086,-410086,,-1436,,,,0,0,410086,0,-128297,,-538383,-538383,102123.0,17283196.0,269141.0,835920.0,1105061.0,425051.0,-16939618.0,67291.0,66503.0,269141.0,67291.0,754737.0,245811.0,2390.0,107922.0,155659.0,27687.0,-37328.0,2328.0,300540.0,-5230.0,300540.0,65965.0,-236903.0,135748.0,479.0,207812.0,-1.0,1.0,,-23330.0,en-US,US,EQUITY,False,Delayed Quote,USD,4,PNK,0.0001,1629379809,0.0,0.0001,0.0001,0.0001,4000,0,INTEGRATED PHARMACEUTICALS INC,PRE,us_market,0.0,1.0E-4 - 1.0E-4,0.0001,0.0,0.0,0,0,finmb_3161389,Other OTC,"Integrated Pharmaceuticals, Inc.",USD,2335,0,0.0,0.0,1.0E-4 - 0.1256,-0.1255,-0.9992038,0.0001,0.1256,-0.5,0.0035287323,-0.0034287323,-0.9716612,-0.04,0.012,0.0002,-0.0001,164668,0.008333333,15,America/New_York,EDT,-14400000,False,False,15.2,,,0.1256,0.0001,0.0002,0.0035,2.33k,,,,,,,,,,,,,3.06%,,,,0.00%,,,1:4,"Sep 19, 2000","Dec 30, 2007","Jun 29, 2008",0.00%,"-4,229.01%",-57.38%,-190.74%,27k,0.00,,23k,-594.13k,-1.7M,-0.0400,,180.85k,0,,,1.00,0.01,-908.64k,76.65k,Value,01420,Healthcare,4,"Integrated Pharmaceuticals, Inc. develops and produces specialty chemicals and nutraceuticals in the United States. It offers compounds and nutraceuticals that have proven therapeutic or nutritional value in humans, plants, and animals. The company also develops technologies for the production of clinically active pharmaceutical compounds, including active small molecules and recombinant DNA technology derived products. In addition, it offers calcium supplements that are used in soft drinks, coffee, tea, soup, dehydrated sauces, and beverages; and fortified bottled water. The company sells its products through distributors and retailers. The company was formerly known as Digital Caddies, Inc. and changed its name to Integrated Pharmaceuticals, Inc. in September 2011. The company was incorporated in 1969 and is based in Fitchburg, Massachusetts.",Fitchburg,978-696-0020,MA,1199059200,United States,86400,310 Authority Drive,978-696-0026,Drug Manufacturers—Specialty & Generic
t-3,INTP,761979.0,0,72532,,-329630,,-329630,45971,22275,-160766,-160766,,-5258,,,,0,27000,187766,4725,-168864,,-329630,-329630,104450.0,16859900.0,340010.0,866429.0,1206439.0,406914.0,-16401235.0,850.0,537.0,340010.0,850.0,890503.0,208616.0,2870.0,108401.0,192987.0,27687.0,-1230.0,1235.0,-194.0,-48000.0,300540.0,-267135.0,-268176.0,135910.0,4725.0,2204.0,-27000.0,-998.0,-194.0,-131394.0,en-US,US,EQUITY,False,Delayed Quote,USD,4,PNK,0.0001,1629379809,0.0,0.0001,0.0001,0.0001,4000,0,INTEGRATED PHARMACEUTICALS INC,PRE,us_market,0.0,1.0E-4 - 1.0E-4,0.0001,0.0,0.0,0,0,finmb_3161389,Other OTC,"Integrated Pharmaceuticals, Inc.",USD,2335,0,0.0,0.0,1.0E-4 - 0.1256,-0.1255,-0.9992038,0.0001,0.1256,-0.5,0.0035287323,-0.0034287323,-0.9716612,-0.04,0.012,0.0002,-0.0001,164668,0.008333333,15,America/New_York,EDT,-14400000,False,False,15.2,,,0.1256,0.0001,0.0002,0.0035,2.33k,,,,,,,,,,,,,3.06%,,,,0.00%,,,1:4,"Sep 19, 2000","Dec 30, 2007","Jun 29, 2008",0.00%,"-4,229.01%",-57.38%,-190.74%,27k,0.00,,23k,-594.13k,-1.7M,-0.0400,,180.85k,0,,,1.00,0.01,-908.64k,76.65k,Value,01420,Healthcare,4,"Integrated Pharmaceuticals, Inc. develops and produces specialty chemicals and nutraceuticals in the United States. It offers compounds and nutraceuticals that have proven therapeutic or nutritional value in humans, plants, and animals. The company also develops technologies for the production of clinically active pharmaceutical compounds, including active small molecules and recombinant DNA technology derived products. In addition, it offers calcium supplements that are used in soft drinks, coffee, tea, soup, dehydrated sauces, and beverages; and fortified bottled water. The company sells its products through distributors and retailers. The company was formerly known as Digital Caddies, Inc. and changed its name to Integrated Pharmaceuticals, Inc. in September 2011. The company was incorporated in 1969 and is based in Fitchburg, Massachusetts.",Fitchburg,978-696-0020,MA,1199059200,United States,86400,310 Authority Drive,978-696-0026,Drug Manufacturers—Specialty & Generic
